Your Pharmacy Market Outlook is ready to download

Download report

Already a Vizient Pharmacy Program member? Access exclusive member insights

Learn how to become a program member

 3.10%
Projected drug price inflation rate
for Jan. 1, 2022-Dec. 31, 2022

Download the report to learn more

Syringe water drop

Top drugs by total member spend 

  1. Adalimumab
  2. Pembrolizumab
  3. Remdesivir

See all top drug spend in the report

Syringes bar chart

Highest class projected price change
DMARDs projected inflation rate is 4.7%

Price increases are anticipated for the high-cost drugs Adalimumab and Etanercept due to delays in bringing biosimilars to market.

Read more in the report

Finger line chart

New! Diabetes-related medication analysis
2.63% projected inflation rate


Insulins are now classified as biologics, opening the door for biosimilars and interchangeable biologics competition.

Read the new section

Pill venn diagram

95% of FDA Accelerated Approvals

Approvals focus on four categories: oncology; infectious disease; toxicology; genetic disorders.

Read more in the report

Moving pharmacy forward

Learn about our Pharmacy Program. We are here to support you.